Compare $GTHP vs $PAVM | Chartloom

Compare

$GTHP vs $PAVM

Guided Therapeutics Inc · PAVmed Inc

GTHP

Guided Therapeutics Inc

PAVM

PAVmed Inc

Compare $GTHP vs $PAVM

Comparing Guided Therapeutics Inc and PAVmed Inc

GTHPGuided Therapeutics Inc

PAVMPAVmed Inc

GTHPGuided Therapeutics Inc

Market cap

$19M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

450.8%

YTD performance

-63.0%

52W performance

-20.0%

FCF yield

-7.8%

PAVMPAVmed Inc

Market cap

$20M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

55.17x

Rev growth (TTM)

-89.0%

YTD performance

-61.9%

52W performance

-80.4%

FCF yield

-39.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GTHP

PAVM

Detailed metrics comparison

GTHP

Guided Therapeutics Inc

PAVM

PAVmed Inc

Market Cap

GTHP$19M

PAVM$20M

Enterprise Value

GTHP$21M

PAVM$31M

Price

GTHP$0.20

PAVM$2.79

P/E Ratio

GTHPN/A

PAVMN/A

P/S Ratio

GTHP29.70x

PAVM178.36x

EV/Sales

GTHP32.92x

PAVM276.84x

EV/EBITDA

GTHP0.00x

PAVM0.77x

P/B Ratio

GTHP33.42x

PAVM0.65x

P/FCF Ratio

GTHPN/A

PAVMN/A

EV/FCF

GTHP-14.21x

PAVM-3.98x

PEG Ratio

GTHPN/A

PAVMN/A

Forward P/E (NTM)

GTHPN/A

PAVMN/A

Forward P/S (NTM)

GTHPN/A

PAVM55.17x

Revenue (TTM)

GTHP$650K

PAVM$112K

Revenue Growth (YoY)

GTHP450.8%

PAVM-89.0%

Forward Rev Growth

GTHP0.0%

PAVM158.1%

Gross Margin (TTM)

GTHP75.8%

PAVM-220.5%

Operating Margin (TTM)

GTHP0.0%

PAVM0.0%

EBITDA Margin (TTM)

GTHP-336.2%

PAVM-23772.3%

Net Margin (TTM)

GTHP-560.6%

PAVM-18417.0%

FCF Margin (TTM)

GTHP-231.7%

PAVM-6948.2%

Net Income (TTM)

GTHP$-4M

PAVM$-21M

FCF (TTM)

GTHP$-2M

PAVM$-8M

EPS (TTM)

GTHP-$0.04

PAVM-$3.29

ROE (TTM)

GTHP-47148.0%

PAVM-3351.0%

ROA (TTM)

GTHP-24393.0%

PAVM-2976.0%

ROIC (TTM)

GTHP-37126.0%

PAVM-2515.0%

Cash

GTHP$12K

PAVM$4M

Debt

GTHP$2M

PAVM$15M

Net Cash/Debt

GTHP$-2M

PAVM$-11M

Current Ratio (TTM)

GTHP0.09x

PAVM1.19x

Quick Ratio (TTM)

GTHP0.00x

PAVM1.05x

Debt/Equity (TTM)

GTHP0.60x

PAVM0.43x

Debt/Assets (TTM)

GTHP0.0%

PAVM0.0%

Interest Coverage (TTM)

GTHPN/A

PAVMN/A

Net Debt/EBITDA (TTM)

GTHP0.00x

PAVM0.00x

Beta

GTHP0.69

PAVM0.86

52W Performance

GTHP-20.0%

PAVM-80.4%

YTD Performance

GTHP-63.0%

PAVM-61.9%

% from 52W High

GTHP-63.0%

PAVM-90.2%

% from 52W Low

GTHP66.7%

PAVM8.1%

Asset Turnover (TTM)

GTHP0.73x

PAVM0.00x

FCF Yield (TTM)

GTHP-7.8%

PAVM-39.0%

Earnings Yield (TTM)

GTHP-18.9%

PAVM-103.3%

Dividend Yield (TTM)

GTHPN/A

PAVMN/A

Rule of 40

GTHP219.2

PAVM-7,037.2

EV/GP/RG

GTHPN/A

PAVMN/A

Ticker research

View GTHP research View PAVM research

Metric	GTHP Guided Therapeutics Inc	PAVM PAVmed Inc
Market & Valuation
Market Cap	$19M	$20M
Enterprise Value	$21M	$31M
Price	$0.20	$2.79
P/E Ratio	N/A	N/A
P/S Ratio	29.70x	178.36x
EV/Sales	32.92x	276.84x
EV/EBITDA	0.00x	0.77x
P/B Ratio	33.42x	0.65x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.21x	-3.98x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	55.17x
Revenue & Growth
Revenue (TTM)	$650K	$112K
Revenue Growth (YoY)	450.8%	-89.0%
Forward Rev Growth	0.0%	158.1%
Profitability
Gross Margin (TTM)	75.8%	-220.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-336.2%	-23772.3%
Net Margin (TTM)	-560.6%	-18417.0%
FCF Margin (TTM)	-231.7%	-6948.2%
Net Income (TTM)	$-4M	$-21M
FCF (TTM)	$-2M	$-8M
EPS (TTM)	-$0.04	-$3.29
ROE (TTM)	-47148.0%	-3351.0%
ROA (TTM)	-24393.0%	-2976.0%
ROIC (TTM)	-37126.0%	-2515.0%
Financial Health
Cash	$12K	$4M
Debt	$2M	$15M
Net Cash/Debt	$-2M	$-11M
Current Ratio (TTM)	0.09x	1.19x
Quick Ratio (TTM)	0.00x	1.05x
Debt/Equity (TTM)	0.60x	0.43x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.69	0.86
52W Performance	-20.0%	-80.4%
YTD Performance	-63.0%	-61.9%
% from 52W High	-63.0%	-90.2%
% from 52W Low	66.7%	8.1%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.00x
FCF Yield (TTM)	-7.8%	-39.0%
Earnings Yield (TTM)	-18.9%	-103.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	219.2	-7,037.2
EV/GP/RG	N/A	N/A
Ticker research	View GTHP research	View PAVM research

Valuation

P/S Ratio

GTHP

29.70x

PAVM

178.36x

EV/FCF

GTHP

-14.21x

PAVM

-3.98x

Growth & revenue

Revenue Growth TTM

GTHP

450.8%

PAVM

-89.0%

Forward Revenue Growth

PAVM

158.1%

GTHP

0.0%

Profitability & performance

Gross Margin

GTHP

75.8%

PAVM

-220.5%

ROE

PAVM

-3351.0%

GTHP

-47148.0%

FCF Yield %

GTHP

-7.8%

PAVM

-39.0%

52-Week Performance

GTHP

-20.0%

PAVM

-80.4%

Detailed metrics comparison

GTHP

Guided Therapeutics Inc

PAVM

PAVmed Inc

Market Cap

GTHP$19M

PAVM$20M

Enterprise Value

GTHP$21M

PAVM$31M

Price

GTHP$0.20

PAVM$2.79

P/E Ratio

GTHPN/A

PAVMN/A

P/S Ratio

GTHP29.70x

PAVM178.36x

EV/Sales

GTHP32.92x

PAVM276.84x

EV/EBITDA

GTHP0.00x

PAVM0.77x

P/B Ratio

GTHP33.42x

PAVM0.65x

P/FCF Ratio

GTHPN/A

PAVMN/A

EV/FCF

GTHP-14.21x

PAVM-3.98x

PEG Ratio

GTHPN/A

PAVMN/A

Forward P/E (NTM)

GTHPN/A

PAVMN/A

Forward P/S (NTM)

GTHPN/A

PAVM55.17x

Revenue (TTM)

GTHP$650K

PAVM$112K

Revenue Growth (YoY)

GTHP450.8%

PAVM-89.0%

Forward Rev Growth

GTHP0.0%

PAVM158.1%

Gross Margin (TTM)

GTHP75.8%

PAVM-220.5%

Operating Margin (TTM)

GTHP0.0%

PAVM0.0%

EBITDA Margin (TTM)

GTHP-336.2%

PAVM-23772.3%

Net Margin (TTM)

GTHP-560.6%

PAVM-18417.0%

FCF Margin (TTM)

GTHP-231.7%

PAVM-6948.2%

Net Income (TTM)

GTHP$-4M

PAVM$-21M

FCF (TTM)

GTHP$-2M

PAVM$-8M

EPS (TTM)

GTHP-$0.04

PAVM-$3.29

ROE (TTM)

GTHP-47148.0%

PAVM-3351.0%

ROA (TTM)

GTHP-24393.0%

PAVM-2976.0%

ROIC (TTM)

GTHP-37126.0%

PAVM-2515.0%

Cash

GTHP$12K

PAVM$4M

Debt

GTHP$2M

PAVM$15M

Net Cash/Debt

GTHP$-2M

PAVM$-11M

Current Ratio (TTM)

GTHP0.09x

PAVM1.19x

Quick Ratio (TTM)

GTHP0.00x

PAVM1.05x

Debt/Equity (TTM)

GTHP0.60x

PAVM0.43x

Debt/Assets (TTM)

GTHP0.0%

PAVM0.0%

Interest Coverage (TTM)

GTHPN/A

PAVMN/A

Net Debt/EBITDA (TTM)

GTHP0.00x

PAVM0.00x

Beta

GTHP0.69

PAVM0.86

52W Performance

GTHP-20.0%

PAVM-80.4%

YTD Performance

GTHP-63.0%

PAVM-61.9%

% from 52W High

GTHP-63.0%

PAVM-90.2%

% from 52W Low

GTHP66.7%

PAVM8.1%

Asset Turnover (TTM)

GTHP0.73x

PAVM0.00x

FCF Yield (TTM)

GTHP-7.8%

PAVM-39.0%

Earnings Yield (TTM)

GTHP-18.9%

PAVM-103.3%

Dividend Yield (TTM)

GTHPN/A

PAVMN/A

Rule of 40

GTHP219.2

PAVM-7,037.2

EV/GP/RG

GTHPN/A

PAVMN/A

Ticker research

View GTHP research View PAVM research

Metric	GTHP Guided Therapeutics Inc	PAVM PAVmed Inc
Market & Valuation
Market Cap	$19M	$20M
Enterprise Value	$21M	$31M
Price	$0.20	$2.79
P/E Ratio	N/A	N/A
P/S Ratio	29.70x	178.36x
EV/Sales	32.92x	276.84x
EV/EBITDA	0.00x	0.77x
P/B Ratio	33.42x	0.65x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.21x	-3.98x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	55.17x
Revenue & Growth
Revenue (TTM)	$650K	$112K
Revenue Growth (YoY)	450.8%	-89.0%
Forward Rev Growth	0.0%	158.1%
Profitability
Gross Margin (TTM)	75.8%	-220.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-336.2%	-23772.3%
Net Margin (TTM)	-560.6%	-18417.0%
FCF Margin (TTM)	-231.7%	-6948.2%
Net Income (TTM)	$-4M	$-21M
FCF (TTM)	$-2M	$-8M
EPS (TTM)	-$0.04	-$3.29
ROE (TTM)	-47148.0%	-3351.0%
ROA (TTM)	-24393.0%	-2976.0%
ROIC (TTM)	-37126.0%	-2515.0%
Financial Health
Cash	$12K	$4M
Debt	$2M	$15M
Net Cash/Debt	$-2M	$-11M
Current Ratio (TTM)	0.09x	1.19x
Quick Ratio (TTM)	0.00x	1.05x
Debt/Equity (TTM)	0.60x	0.43x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.69	0.86
52W Performance	-20.0%	-80.4%
YTD Performance	-63.0%	-61.9%
% from 52W High	-63.0%	-90.2%
% from 52W Low	66.7%	8.1%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.00x
FCF Yield (TTM)	-7.8%	-39.0%
Earnings Yield (TTM)	-18.9%	-103.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	219.2	-7,037.2
EV/GP/RG	N/A	N/A
Ticker research	View GTHP research	View PAVM research